ArticleAnnals of the American Thoracic Society2025

Use of Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease at Expert Scleroderma Centers in the United States.

Yiming Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.